Authors: Judit Dénes, Francesca Swords, Eleanor Rattenberry, Karen Stals, Martina Owens, Treena Cranston, Paraskevi Xekouki, Linda B. Moran, Ajith Kumar, Christopher A. Wassif, Naomi Fersht, Stephanie E Baldeweg, Damian G. Morris, Stafford L. Lightman, Amar Agha, Aled Rees, Joan Grieve, Michael Powell, Cesar Luiz Boguszewski, Pinaki Dutta, Rajesh V. Thakker, Umasuthan Srirangalingam, Christopher J. Thompson, Maralyn Druce, Claire E Higham, Julian R. E. Davis, Rosalind A. Eeles, Mark Stevenson, Brendan O'Sullivan, Phillipe Taniere, Kassiani Skordilis, Plamena Gabrovska, Anne Barlier, Susan M. Webb, Anna Aulinas, William Drake, John S. Bevan, Cristina Preda, Nadezhda Dalantaeva, Antônio Ribeiro-Oliveira, Isabel Tena Garcia, Galina Yordanova, Violeta Iotova, Jane Evanson, Ashley B. Grossman, Jacqueline Trouillas, Sian Ellard, Constantine A. Stratakis, Eamonn R. Maher, Federico Roncaroli, Márta Korbonits
Venue: The Journal of Clinical Endocrinology & Metabolism
Type: Publication
Abstract: Context: Pituitary adenomas and pheochromocytomas/paragangliomas (pheo/PGL) can occur in the same patient or in the same family. Coexistence of the two diseases could be due to either a common pathogenic mechanism or a coincidence. Objective: The objective of the investigation was to study the possible coexistence of pituitary adenoma and pheo/PGL. Design: Thirty-nine cases of sporadic or familial pheo/PGL and pituitary adenomas were investigated. Known pheo/PGL genes (SDHA-D, SDHAF2, RET, VHL, TMEM127, MAX, FH) and pituitary adenoma genes (MEN...
(read more)
Topics: 
Cancer research
Pathology
Internal medicine
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...